- Report
- January 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- May 2023
- 140 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- December 2023
- 146 Pages
Global
From €3997EUR$4,450USD£3,414GBP
- Report
- October 2025
- 84 Pages
Saudi Arabia
From €4042EUR$4,500USD£3,453GBP
- Report
- October 2025
- 94 Pages
Philippines
From €4042EUR$4,500USD£3,453GBP
- Report
- October 2025
- 92 Pages
Qatar
From €4042EUR$4,500USD£3,453GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$4,174USD£3,094GBP
- Report
- November 2025
- 132 Pages
Global
From €853EUR$950USD£729GBP
The Viral Clearance market is a subset of the biotechnology industry that focuses on the development of technologies and processes to reduce the presence of viruses in biopharmaceutical products. This is done through the use of viral clearance strategies such as filtration, chromatography, and inactivation. These strategies are used to reduce the risk of contamination and ensure the safety of biopharmaceutical products.
Viral clearance is an important part of the biopharmaceutical manufacturing process, as it helps to ensure the safety and efficacy of the products. It is also used to reduce the risk of cross-contamination between batches of biopharmaceuticals.
Some companies in the Viral Clearance market include Merck, Sartorius, Pall Corporation, and Thermo Fisher Scientific. Show Less Read more